SlideShare une entreprise Scribd logo
1  sur  37
HRD 129 Graduation Project
SUPERVISED BY DR/ MOHAMED ALY
1
Sanofi Profile
2
Sanofi Profile
3
History
4
Company Products
5
Vision, Mission
& Objectives
Vision
To be the most admired and best-in-class healthcare partner enhancing the quality of life
through prevention, cure and innovation with commitment towards society and environment.
Mission
SHAPING TOMORROW’S HEALTH
As researchers, we have it in us to be extraordinary bold and hopeful because in research what
will happen ten or fifteen years from now I going to be determined by what we do today. We
have the power to bring an idea from a scientist’s mind directly to patients.
• From science to solutions
• Understanding the needs of patients better
Objectives
- Over 2012-2016, Sanofi expects to deliver sales growth of at least 5% on average1and higher
business EPS2 growth1.
- Since the end of 2008, Sanofi has led an impressive transformation by executing a new
strategy focused on
- Three pillars: increase innovation in R&D, pursue external growth opportunities, and adapt
structure for future
- Challenges and opportunities. Over this period, the group has centered its activities around
six growth
- platforms including Emerging Markets6, Human Vaccines, Diabetes solutions, Consumer
Health Care,
- Innovative Products and Animal Health.
6
Core Values
At Sanofi, we embrace five core Values
1. Innovation.
2. Confidence
3. Respect
4. Solidarity
5. Integrity
7
The Project objective is to discuss
(Acquisitions Problems):
Acquisition and mergers may has a lot of problems as
1- Many of the most talented business leaders not experts in various stages of mergers and
acquisitions, they cannot on go with the new demands of the business.
Some of them take so much time to understand mergers new goals.
2- Merger training is often overlooked and can present obstacles if not implemented promptly.
3-Employee productivity often falls where major staffing decisions are being made. The fear of
making a mistake can cause a drop in creativity or efficiency.
8
But in Sanofi the problems are slightly
different
1- First problem is as a result of acquisitions Sanofi has a large scale of employees with the same age,
same job, same qualifications and knowledge which leads to very narrow career pathway. As there is
employees who are in the company since 10 years at the same job.
2- Second problem is difference in packages with employees in the same positions which leads to
make employees feel with unfairness and makes them unsatisfied.
3- Second problem will lead us to the third one which is “How to balance between them”. When the
HR sector tries to balance it they finds that there is two ways to do it
A- By lowering salaries of the highest employees with is impossible to do.
B- Or by increases the salary level of the lower ones which will make load on the company budget.
4- And finally because of unsatisfied employees there is a performance reduction which leads to great
loss to the company.
9
Business strategy
The objective of business strategy of Sanofi is to improve the competitive position of the
organization in the market and supply the patients with the best products and services.
Sanofi can achieve that objective by the following
No physician, researcher, or healthcare company works in isolation. We need each other, and many
others, to help move healthcare forward
Example of our business level strategy
Focus strategy:
In order to be Number one pharmaceutical company in the diabetes therapeutic area , Sanofi
business strategy is to separate diabetes as a specialized business unit to be more focused in the
diabetes area
Oral drugs ( type 2 )
Amaryl
Toujeo is expected to be available in the U.S. at the beginning of Q2 2015.
Injected insulin
Insuman
Lantus
10
Business strategy
Differentiation strategy
They also focus on producing a new products with unique features
For example:
Prescription Afrezza® is a man-made rapid acting inhaled insulin breathed through your lungs and
is used to control high blood sugar in adults with type 1 and type 2 diabetes.
11
Corporate Strategies
Directional strategy: Sanofi strategy is toward growth and that obvious through acquisition and merges that done
at the last few years like merge with Aventis and accusation of Winthrop. This growth strategy in Sanofi carry out
into two arms
1-concentration strategy:
-Horizontal growth
through penetration of new market also through acquisitions:
Recently they acquired “Genzyme” (an American biotechnology company) which will provide Sanofi with new
products
Emerging markets: Sanofi intends to retain its number one position through greater focus on priority countries
-Vertical growth
through backward integration by establishing new factory in each affiliate
12
Corporate strategies
.
2-Diversfication strategy:
-Concentric strategy by launching new products in different therapeutic areas especially in diabetes. Our strategy is to cover the many different types of patient
1-Type 1 diabetic patient with Lantus and Apidra and Insuman ,
2- type 2 diabetic patient with Amaryl and Doani and luxmyia,
3-patient type 1 can’t afford Lantus price with Insuman
4- type 2 diabetic patient who can’t afford by Amaryl and Doanil
-Sanofi intend to produce more generic drugs
different between Brand and Generic drugs
Through its generics products, Sanofi operates worldwide using already strong brands like Zentiva, Medley, Genfar, Winthrop, and Globalpharma.
Example of generic drugs as
Wintriaxone vials
Windipine tablets
13
Organization Structure
•Ownership structure is corporation structure.
•Total number of employees world wide over
110,000 employees in 100 countries in 112
industrial site.
•Total number of employees in Egypt is 1200
employees including 450 employees in the all
departments in the factory.
•About 600 employees in sales department in
Egypt.
14
Organization Chart ( Matrix Type)
15
General Manager For Egypt &
Sudan
CFO
Operation
Support
Director
Business
Excellence
Director
4 Business
Unit
Director
8 Line
Managers
57 District
Managers
456 Medical
Representative
Commercial
Director
Key Account
Manager
10 Key
Account
Supervisor
Medical &
Regulatory
Affairs
Director
Human
Resources
Director
Head Of
Legal
Public
Affairs &
communicati
on Director
Supply
Chain
Director
Country
Security
head
Executive
Secretary
Office
Manage
Recruitment Strategy
Sanofi recruit and retain a diverse workforce to meet
the needs of the organization, where our staff needs to
employ an individual who would help them reach
new customers in our products disease areas to
improve our performance.
Maintaining fairness/equity in the recruitment
process, while recruiting the new employees by
reviewing recruitment and selection processes to
ensure that current and potential employees are
against discrimination.
16
Implementation
17
1-Recruitment calendar:
Apply the recruitment calendar to make sure that
all the vacancies will be filled within the target
date .
2- Sourcing:
External sourcing
Internal sourcing
Head Hunting
Employee Referral Program ( I Hire Program)
using employee referral recruitment is very
efficient way to get good calibers from similar
culture to company employees.
Internal Hiring ( Work day Program)
18
Evaluation of :
-Recruitment calendar
-External and internal sourcing
-Recruitment Survey
19
Compensation & Benefits Strategy
** implantation :-
1- to sustain and gain employees
2- the annual incentive plan ( performance orianted)
3- market based approach
It divided to 2 parts :-
A- direct compensation:-
basic salary
cash incentive
Non-cash incentive
B- Indirect compensation (benefits) :-
20
Sanofi benefit programs
21
Sanofi benefit programs
22
Indirect compensation (benefits)
•Work/life benefits :-
includes annual leaves and paid leaves
Mobile ,transportation and meals allowances .
•Financial protection benefits
As disability coverage and life insurance.
•Training courses
23
Strategy Evaluation
Finally evaluation :-
By several ways
A- statisfaction survey
B- measure turnover rate
C- measure employee's commitment , retention and motivation.
D- evaluation of performance rate
E- reporting to exit interview to evaluate reasons of resigning.
24
Training and Development strategy
•It is purpose to link business needs and to improve the quality of performance.
•This Training and Development Strategy will be implemented in the period 2015-2016.
•Reason help to take this training strategy:
•Many Job opportunities offered and not find the fit criteria internally
•It is crucial for prepare employee at high level of competences and find career development
opportunities
•Prepare staff with high competitive edge in market adapted with external environment and have
the ability to leader and compete.
•Expansion of SANOFI in different way.
25
Training and Development strategy
26
Training Methods
On the job
training
Self- managed
learning
Group
learning
Tutor led
interventions
Online
Training
Training and Development strategy
Authority of Implementation
senior management, HR/Training and Development Unit, line managers and job holders.
•Training in Sanofi divided into :-
*10% educational based training -----> class room training + e learning .
*20% relation based feedback activities-----> (coaching &field trainer feedback )
70% job based development-------> role expansion ( increase responsibility, fill in for manager
27
Training and Development strategy
28
Training
project
Future Access
Ashbal
Program
Work day
Application
Training and Development strategy
Future Access
It is field based training provided to over 400 pharmacy students from all over Egypt .
This project not only for students but also for field force employees at Sanofi as they can go on
job training by doing district sales managers, human resources & marketing tasks in the project .
29
Training and Development strategy
Work Day Application
 similar to LinkedIn application but only for Sanofi employees worldwide.
 This application helps employees to put all their experience , courses , skills , qualifications and
in what they want to grow up.
That application also help management to find the qualified person for any vacant exist.
 HR have access in this App. to find Applicable Vacant in Sanofi world wide for talented people
and people with Saturated position.
30
Training and Development strategy
31
Training and Development strategy
32
Training and Development strategy
Ashbal Program
Kick off Program in March 2016 .
It is a 6 months traineeship allow 100 sales employees to work in
Different 40 other departments in Sanofi company. Each on according his IDP.
(30 sales , 30 Marketing , 10 key Account , 10 HR and Training , 10 Business Development and
10 Communication .
That program help employees to grow in other departments.
33
Training Evaluation : Kirkpatrick’s4 Four Level Model of
Evaluation, and The Phillips“ROI” methodology
34
• from evaluations filled out by attendees at the conclusion of the training program in survey formatL1 – Reaction (in class):
• By exam or role play to assess how much the participants learned and applied in the learning experienceL2– Learning evaluation (in class):
• evaluated by direct managers and field trainers
• To observe which the knowledge, skills and abilities taught in the classroom are being used on the job
L3– Application to the job (also
called Transfer )
• on organizational productivity, improved customer satisfaction, and the organization’s strategic business
plan
• Impact ( change ) and ROI ( investment )
L4 – Evaluating the impact and
ROI (also called results):
• through direct managers and HR
L 5 – Evaluating the performance
Appraisal pre & post the training:
Culture and Behavior of Sanofi
Sanofi culture Depend on Respect ,leadership ,cooperation ,creativity and innovation.
Recognition and rewards.
Learning and personal development
Development and mobility
Sanofi behavior depend on adapting with changes.
Ex. ( modernizing the way of sales and marketing )
35
Conclusion
36
Sanofi
is a multinational
pharmaceutical company
Problem
Retention of employee
in same position
Overcome
by investment on
employee
Evaluation
Increase loyalty , encourage people to improve and
success and high performance and achievement
37

Contenu connexe

Tendances

Competitive advantage and strategy formulation process
Competitive advantage and strategy formulation processCompetitive advantage and strategy formulation process
Competitive advantage and strategy formulation processvitusmaren
 
Pfizer business strategy
Pfizer business strategyPfizer business strategy
Pfizer business strategyPavanPardeshi1
 
Sandoz Company Presentation
Sandoz Company PresentationSandoz Company Presentation
Sandoz Company PresentationSandoz
 
SANOFI_Presentation_EN
SANOFI_Presentation_ENSANOFI_Presentation_EN
SANOFI_Presentation_ENAnna Yakovenko
 
Analysis of the Pharmaceutical Industry
Analysis of the Pharmaceutical IndustryAnalysis of the Pharmaceutical Industry
Analysis of the Pharmaceutical IndustryHinduReddyAnumula
 
PESTAL and SWOT analysis on NESTLE Brand
PESTAL and SWOT analysis on NESTLE BrandPESTAL and SWOT analysis on NESTLE Brand
PESTAL and SWOT analysis on NESTLE BrandHarshdeep Champaneri
 
Marketing Strategy of Sun Pharmaceuticals
Marketing Strategy of Sun PharmaceuticalsMarketing Strategy of Sun Pharmaceuticals
Marketing Strategy of Sun PharmaceuticalsAman Dube
 
Sanofi Q4 and full year 2022 results
Sanofi Q4 and full year 2022 resultsSanofi Q4 and full year 2022 results
Sanofi Q4 and full year 2022 resultsSanofi
 
Overview of oncology market
Overview of oncology marketOverview of oncology market
Overview of oncology marketvikas gore
 
swot on pestle analysis of spain
swot on pestle analysis of spainswot on pestle analysis of spain
swot on pestle analysis of spainashwin bas
 
Pfizer-Strategic Management Case
Pfizer-Strategic Management CasePfizer-Strategic Management Case
Pfizer-Strategic Management CaseSanjaya Sanjaya
 
Corporate Strategy Assignment - The Global Pharmaceutical Industry
Corporate Strategy Assignment - The Global Pharmaceutical IndustryCorporate Strategy Assignment - The Global Pharmaceutical Industry
Corporate Strategy Assignment - The Global Pharmaceutical IndustryAmany Hamza
 
Pharmaceutical Porter analysis
Pharmaceutical Porter analysisPharmaceutical Porter analysis
Pharmaceutical Porter analysisPharm Net
 
Product Mix of Novartis
Product Mix of NovartisProduct Mix of Novartis
Product Mix of NovartisAnimesh Gupta
 
Comparison - Unilever Vs P&G- International Business and Marketing Stategies
Comparison - Unilever Vs P&G- International Business and Marketing StategiesComparison - Unilever Vs P&G- International Business and Marketing Stategies
Comparison - Unilever Vs P&G- International Business and Marketing StategiesSwapnil Mali
 

Tendances (20)

Competitive advantage and strategy formulation process
Competitive advantage and strategy formulation processCompetitive advantage and strategy formulation process
Competitive advantage and strategy formulation process
 
Pfizer business strategy
Pfizer business strategyPfizer business strategy
Pfizer business strategy
 
BUSINESS STARATEGY AND POLICY PROJECT
BUSINESS STARATEGY AND POLICY PROJECTBUSINESS STARATEGY AND POLICY PROJECT
BUSINESS STARATEGY AND POLICY PROJECT
 
Sandoz Company Presentation
Sandoz Company PresentationSandoz Company Presentation
Sandoz Company Presentation
 
SANOFI_Presentation_EN
SANOFI_Presentation_ENSANOFI_Presentation_EN
SANOFI_Presentation_EN
 
Analysis of the Pharmaceutical Industry
Analysis of the Pharmaceutical IndustryAnalysis of the Pharmaceutical Industry
Analysis of the Pharmaceutical Industry
 
Pfizer Inc
Pfizer IncPfizer Inc
Pfizer Inc
 
PESTAL and SWOT analysis on NESTLE Brand
PESTAL and SWOT analysis on NESTLE BrandPESTAL and SWOT analysis on NESTLE Brand
PESTAL and SWOT analysis on NESTLE Brand
 
Marketing Strategy of Sun Pharmaceuticals
Marketing Strategy of Sun PharmaceuticalsMarketing Strategy of Sun Pharmaceuticals
Marketing Strategy of Sun Pharmaceuticals
 
Sanofi Q4 and full year 2022 results
Sanofi Q4 and full year 2022 resultsSanofi Q4 and full year 2022 results
Sanofi Q4 and full year 2022 results
 
Pfizer case study
Pfizer case studyPfizer case study
Pfizer case study
 
Rise and Fall of Xerox
Rise and Fall of XeroxRise and Fall of Xerox
Rise and Fall of Xerox
 
Novartis Oncology Strategy
Novartis Oncology StrategyNovartis Oncology Strategy
Novartis Oncology Strategy
 
Overview of oncology market
Overview of oncology marketOverview of oncology market
Overview of oncology market
 
swot on pestle analysis of spain
swot on pestle analysis of spainswot on pestle analysis of spain
swot on pestle analysis of spain
 
Pfizer-Strategic Management Case
Pfizer-Strategic Management CasePfizer-Strategic Management Case
Pfizer-Strategic Management Case
 
Corporate Strategy Assignment - The Global Pharmaceutical Industry
Corporate Strategy Assignment - The Global Pharmaceutical IndustryCorporate Strategy Assignment - The Global Pharmaceutical Industry
Corporate Strategy Assignment - The Global Pharmaceutical Industry
 
Pharmaceutical Porter analysis
Pharmaceutical Porter analysisPharmaceutical Porter analysis
Pharmaceutical Porter analysis
 
Product Mix of Novartis
Product Mix of NovartisProduct Mix of Novartis
Product Mix of Novartis
 
Comparison - Unilever Vs P&G- International Business and Marketing Stategies
Comparison - Unilever Vs P&G- International Business and Marketing StategiesComparison - Unilever Vs P&G- International Business and Marketing Stategies
Comparison - Unilever Vs P&G- International Business and Marketing Stategies
 

Similaire à Sanofi Graduation Presentation

Strength weakness of aci pharmaceuticals ltd. using balanced scorecard method
Strength  weakness of aci pharmaceuticals ltd. using balanced scorecard methodStrength  weakness of aci pharmaceuticals ltd. using balanced scorecard method
Strength weakness of aci pharmaceuticals ltd. using balanced scorecard methodFahimNeloy47
 
sanofi-150823141348-lva1-app6892.pdf
sanofi-150823141348-lva1-app6892.pdfsanofi-150823141348-lva1-app6892.pdf
sanofi-150823141348-lva1-app6892.pdfRishabh Mishra
 
BUSI 330Collaborative Marketing Plan Final Draft Instructions.docx
BUSI 330Collaborative Marketing Plan Final Draft Instructions.docxBUSI 330Collaborative Marketing Plan Final Draft Instructions.docx
BUSI 330Collaborative Marketing Plan Final Draft Instructions.docxrichardnorman90310
 
The Journey Toward Launch Excellence.pdf
The Journey Toward Launch Excellence.pdfThe Journey Toward Launch Excellence.pdf
The Journey Toward Launch Excellence.pdfyasmineabdelkarim5
 
Project 1 - Case StudyInstructionsThe use of digital media w.docx
Project 1 - Case StudyInstructionsThe use of digital media w.docxProject 1 - Case StudyInstructionsThe use of digital media w.docx
Project 1 - Case StudyInstructionsThe use of digital media w.docxwkyra78
 
Beximco Pharma EXODUS
Beximco Pharma EXODUSBeximco Pharma EXODUS
Beximco Pharma EXODUSNadim Siddik
 
CV - Lisa Finlay -2
CV - Lisa Finlay -2CV - Lisa Finlay -2
CV - Lisa Finlay -2Lisa Finlay
 
Schering Plough - Pharma Career Day
Schering Plough - Pharma Career DaySchering Plough - Pharma Career Day
Schering Plough - Pharma Career DayPharmaConnectME
 
IMC Plan for BRAND’S®
IMC Plan for BRAND’S®IMC Plan for BRAND’S®
IMC Plan for BRAND’S®Vincs Kong
 
Running head IMPROVING FIRM BEHAVIOR THROUGH EMPLOYEE ENGAGEMENT .docx
Running head IMPROVING FIRM BEHAVIOR THROUGH EMPLOYEE ENGAGEMENT .docxRunning head IMPROVING FIRM BEHAVIOR THROUGH EMPLOYEE ENGAGEMENT .docx
Running head IMPROVING FIRM BEHAVIOR THROUGH EMPLOYEE ENGAGEMENT .docxcowinhelen
 
Application Of Bsc
Application Of BscApplication Of Bsc
Application Of Bscmufaroo
 
Application Of Bsc
Application Of BscApplication Of Bsc
Application Of Bscmufaroo
 
Application of Balance Scorecard
Application of Balance ScorecardApplication of Balance Scorecard
Application of Balance Scorecardmufaroo
 
FUNCTIONAL LEVEL STRATEGY.pptx
FUNCTIONAL LEVEL STRATEGY.pptxFUNCTIONAL LEVEL STRATEGY.pptx
FUNCTIONAL LEVEL STRATEGY.pptxUkhai
 
ConfluCore Competency Brief - January 2017
ConfluCore Competency Brief - January 2017ConfluCore Competency Brief - January 2017
ConfluCore Competency Brief - January 2017Usman A. Ghani
 

Similaire à Sanofi Graduation Presentation (20)

Strength weakness of aci pharmaceuticals ltd. using balanced scorecard method
Strength  weakness of aci pharmaceuticals ltd. using balanced scorecard methodStrength  weakness of aci pharmaceuticals ltd. using balanced scorecard method
Strength weakness of aci pharmaceuticals ltd. using balanced scorecard method
 
sanofi-150823141348-lva1-app6892.pdf
sanofi-150823141348-lva1-app6892.pdfsanofi-150823141348-lva1-app6892.pdf
sanofi-150823141348-lva1-app6892.pdf
 
Reda Consult,summary 2016
Reda Consult,summary 2016Reda Consult,summary 2016
Reda Consult,summary 2016
 
BUSI 330Collaborative Marketing Plan Final Draft Instructions.docx
BUSI 330Collaborative Marketing Plan Final Draft Instructions.docxBUSI 330Collaborative Marketing Plan Final Draft Instructions.docx
BUSI 330Collaborative Marketing Plan Final Draft Instructions.docx
 
Hossam Mohamed Sharaf ElDin
Hossam Mohamed Sharaf ElDinHossam Mohamed Sharaf ElDin
Hossam Mohamed Sharaf ElDin
 
The Journey Toward Launch Excellence.pdf
The Journey Toward Launch Excellence.pdfThe Journey Toward Launch Excellence.pdf
The Journey Toward Launch Excellence.pdf
 
Goals of PepsiCo.docx
Goals  of PepsiCo.docxGoals  of PepsiCo.docx
Goals of PepsiCo.docx
 
Hilal
HilalHilal
Hilal
 
Project 1 - Case StudyInstructionsThe use of digital media w.docx
Project 1 - Case StudyInstructionsThe use of digital media w.docxProject 1 - Case StudyInstructionsThe use of digital media w.docx
Project 1 - Case StudyInstructionsThe use of digital media w.docx
 
Beximco Pharma EXODUS
Beximco Pharma EXODUSBeximco Pharma EXODUS
Beximco Pharma EXODUS
 
CV - Lisa Finlay -2
CV - Lisa Finlay -2CV - Lisa Finlay -2
CV - Lisa Finlay -2
 
Schering Plough - Pharma Career Day
Schering Plough - Pharma Career DaySchering Plough - Pharma Career Day
Schering Plough - Pharma Career Day
 
IMC Plan for BRAND’S®
IMC Plan for BRAND’S®IMC Plan for BRAND’S®
IMC Plan for BRAND’S®
 
Running head IMPROVING FIRM BEHAVIOR THROUGH EMPLOYEE ENGAGEMENT .docx
Running head IMPROVING FIRM BEHAVIOR THROUGH EMPLOYEE ENGAGEMENT .docxRunning head IMPROVING FIRM BEHAVIOR THROUGH EMPLOYEE ENGAGEMENT .docx
Running head IMPROVING FIRM BEHAVIOR THROUGH EMPLOYEE ENGAGEMENT .docx
 
Beximco pharma
Beximco pharmaBeximco pharma
Beximco pharma
 
Application Of Bsc
Application Of BscApplication Of Bsc
Application Of Bsc
 
Application Of Bsc
Application Of BscApplication Of Bsc
Application Of Bsc
 
Application of Balance Scorecard
Application of Balance ScorecardApplication of Balance Scorecard
Application of Balance Scorecard
 
FUNCTIONAL LEVEL STRATEGY.pptx
FUNCTIONAL LEVEL STRATEGY.pptxFUNCTIONAL LEVEL STRATEGY.pptx
FUNCTIONAL LEVEL STRATEGY.pptx
 
ConfluCore Competency Brief - January 2017
ConfluCore Competency Brief - January 2017ConfluCore Competency Brief - January 2017
ConfluCore Competency Brief - January 2017
 

Sanofi Graduation Presentation

  • 1. HRD 129 Graduation Project SUPERVISED BY DR/ MOHAMED ALY 1
  • 6. Vision, Mission & Objectives Vision To be the most admired and best-in-class healthcare partner enhancing the quality of life through prevention, cure and innovation with commitment towards society and environment. Mission SHAPING TOMORROW’S HEALTH As researchers, we have it in us to be extraordinary bold and hopeful because in research what will happen ten or fifteen years from now I going to be determined by what we do today. We have the power to bring an idea from a scientist’s mind directly to patients. • From science to solutions • Understanding the needs of patients better Objectives - Over 2012-2016, Sanofi expects to deliver sales growth of at least 5% on average1and higher business EPS2 growth1. - Since the end of 2008, Sanofi has led an impressive transformation by executing a new strategy focused on - Three pillars: increase innovation in R&D, pursue external growth opportunities, and adapt structure for future - Challenges and opportunities. Over this period, the group has centered its activities around six growth - platforms including Emerging Markets6, Human Vaccines, Diabetes solutions, Consumer Health Care, - Innovative Products and Animal Health. 6
  • 7. Core Values At Sanofi, we embrace five core Values 1. Innovation. 2. Confidence 3. Respect 4. Solidarity 5. Integrity 7
  • 8. The Project objective is to discuss (Acquisitions Problems): Acquisition and mergers may has a lot of problems as 1- Many of the most talented business leaders not experts in various stages of mergers and acquisitions, they cannot on go with the new demands of the business. Some of them take so much time to understand mergers new goals. 2- Merger training is often overlooked and can present obstacles if not implemented promptly. 3-Employee productivity often falls where major staffing decisions are being made. The fear of making a mistake can cause a drop in creativity or efficiency. 8
  • 9. But in Sanofi the problems are slightly different 1- First problem is as a result of acquisitions Sanofi has a large scale of employees with the same age, same job, same qualifications and knowledge which leads to very narrow career pathway. As there is employees who are in the company since 10 years at the same job. 2- Second problem is difference in packages with employees in the same positions which leads to make employees feel with unfairness and makes them unsatisfied. 3- Second problem will lead us to the third one which is “How to balance between them”. When the HR sector tries to balance it they finds that there is two ways to do it A- By lowering salaries of the highest employees with is impossible to do. B- Or by increases the salary level of the lower ones which will make load on the company budget. 4- And finally because of unsatisfied employees there is a performance reduction which leads to great loss to the company. 9
  • 10. Business strategy The objective of business strategy of Sanofi is to improve the competitive position of the organization in the market and supply the patients with the best products and services. Sanofi can achieve that objective by the following No physician, researcher, or healthcare company works in isolation. We need each other, and many others, to help move healthcare forward Example of our business level strategy Focus strategy: In order to be Number one pharmaceutical company in the diabetes therapeutic area , Sanofi business strategy is to separate diabetes as a specialized business unit to be more focused in the diabetes area Oral drugs ( type 2 ) Amaryl Toujeo is expected to be available in the U.S. at the beginning of Q2 2015. Injected insulin Insuman Lantus 10
  • 11. Business strategy Differentiation strategy They also focus on producing a new products with unique features For example: Prescription Afrezza® is a man-made rapid acting inhaled insulin breathed through your lungs and is used to control high blood sugar in adults with type 1 and type 2 diabetes. 11
  • 12. Corporate Strategies Directional strategy: Sanofi strategy is toward growth and that obvious through acquisition and merges that done at the last few years like merge with Aventis and accusation of Winthrop. This growth strategy in Sanofi carry out into two arms 1-concentration strategy: -Horizontal growth through penetration of new market also through acquisitions: Recently they acquired “Genzyme” (an American biotechnology company) which will provide Sanofi with new products Emerging markets: Sanofi intends to retain its number one position through greater focus on priority countries -Vertical growth through backward integration by establishing new factory in each affiliate 12
  • 13. Corporate strategies . 2-Diversfication strategy: -Concentric strategy by launching new products in different therapeutic areas especially in diabetes. Our strategy is to cover the many different types of patient 1-Type 1 diabetic patient with Lantus and Apidra and Insuman , 2- type 2 diabetic patient with Amaryl and Doani and luxmyia, 3-patient type 1 can’t afford Lantus price with Insuman 4- type 2 diabetic patient who can’t afford by Amaryl and Doanil -Sanofi intend to produce more generic drugs different between Brand and Generic drugs Through its generics products, Sanofi operates worldwide using already strong brands like Zentiva, Medley, Genfar, Winthrop, and Globalpharma. Example of generic drugs as Wintriaxone vials Windipine tablets 13
  • 14. Organization Structure •Ownership structure is corporation structure. •Total number of employees world wide over 110,000 employees in 100 countries in 112 industrial site. •Total number of employees in Egypt is 1200 employees including 450 employees in the all departments in the factory. •About 600 employees in sales department in Egypt. 14
  • 15. Organization Chart ( Matrix Type) 15 General Manager For Egypt & Sudan CFO Operation Support Director Business Excellence Director 4 Business Unit Director 8 Line Managers 57 District Managers 456 Medical Representative Commercial Director Key Account Manager 10 Key Account Supervisor Medical & Regulatory Affairs Director Human Resources Director Head Of Legal Public Affairs & communicati on Director Supply Chain Director Country Security head Executive Secretary Office Manage
  • 16. Recruitment Strategy Sanofi recruit and retain a diverse workforce to meet the needs of the organization, where our staff needs to employ an individual who would help them reach new customers in our products disease areas to improve our performance. Maintaining fairness/equity in the recruitment process, while recruiting the new employees by reviewing recruitment and selection processes to ensure that current and potential employees are against discrimination. 16
  • 17. Implementation 17 1-Recruitment calendar: Apply the recruitment calendar to make sure that all the vacancies will be filled within the target date . 2- Sourcing: External sourcing Internal sourcing Head Hunting Employee Referral Program ( I Hire Program) using employee referral recruitment is very efficient way to get good calibers from similar culture to company employees.
  • 18. Internal Hiring ( Work day Program) 18
  • 19. Evaluation of : -Recruitment calendar -External and internal sourcing -Recruitment Survey 19
  • 20. Compensation & Benefits Strategy ** implantation :- 1- to sustain and gain employees 2- the annual incentive plan ( performance orianted) 3- market based approach It divided to 2 parts :- A- direct compensation:- basic salary cash incentive Non-cash incentive B- Indirect compensation (benefits) :- 20
  • 23. Indirect compensation (benefits) •Work/life benefits :- includes annual leaves and paid leaves Mobile ,transportation and meals allowances . •Financial protection benefits As disability coverage and life insurance. •Training courses 23
  • 24. Strategy Evaluation Finally evaluation :- By several ways A- statisfaction survey B- measure turnover rate C- measure employee's commitment , retention and motivation. D- evaluation of performance rate E- reporting to exit interview to evaluate reasons of resigning. 24
  • 25. Training and Development strategy •It is purpose to link business needs and to improve the quality of performance. •This Training and Development Strategy will be implemented in the period 2015-2016. •Reason help to take this training strategy: •Many Job opportunities offered and not find the fit criteria internally •It is crucial for prepare employee at high level of competences and find career development opportunities •Prepare staff with high competitive edge in market adapted with external environment and have the ability to leader and compete. •Expansion of SANOFI in different way. 25
  • 26. Training and Development strategy 26 Training Methods On the job training Self- managed learning Group learning Tutor led interventions Online Training
  • 27. Training and Development strategy Authority of Implementation senior management, HR/Training and Development Unit, line managers and job holders. •Training in Sanofi divided into :- *10% educational based training -----> class room training + e learning . *20% relation based feedback activities-----> (coaching &field trainer feedback ) 70% job based development-------> role expansion ( increase responsibility, fill in for manager 27
  • 28. Training and Development strategy 28 Training project Future Access Ashbal Program Work day Application
  • 29. Training and Development strategy Future Access It is field based training provided to over 400 pharmacy students from all over Egypt . This project not only for students but also for field force employees at Sanofi as they can go on job training by doing district sales managers, human resources & marketing tasks in the project . 29
  • 30. Training and Development strategy Work Day Application  similar to LinkedIn application but only for Sanofi employees worldwide.  This application helps employees to put all their experience , courses , skills , qualifications and in what they want to grow up. That application also help management to find the qualified person for any vacant exist.  HR have access in this App. to find Applicable Vacant in Sanofi world wide for talented people and people with Saturated position. 30
  • 33. Training and Development strategy Ashbal Program Kick off Program in March 2016 . It is a 6 months traineeship allow 100 sales employees to work in Different 40 other departments in Sanofi company. Each on according his IDP. (30 sales , 30 Marketing , 10 key Account , 10 HR and Training , 10 Business Development and 10 Communication . That program help employees to grow in other departments. 33
  • 34. Training Evaluation : Kirkpatrick’s4 Four Level Model of Evaluation, and The Phillips“ROI” methodology 34 • from evaluations filled out by attendees at the conclusion of the training program in survey formatL1 – Reaction (in class): • By exam or role play to assess how much the participants learned and applied in the learning experienceL2– Learning evaluation (in class): • evaluated by direct managers and field trainers • To observe which the knowledge, skills and abilities taught in the classroom are being used on the job L3– Application to the job (also called Transfer ) • on organizational productivity, improved customer satisfaction, and the organization’s strategic business plan • Impact ( change ) and ROI ( investment ) L4 – Evaluating the impact and ROI (also called results): • through direct managers and HR L 5 – Evaluating the performance Appraisal pre & post the training:
  • 35. Culture and Behavior of Sanofi Sanofi culture Depend on Respect ,leadership ,cooperation ,creativity and innovation. Recognition and rewards. Learning and personal development Development and mobility Sanofi behavior depend on adapting with changes. Ex. ( modernizing the way of sales and marketing ) 35
  • 36. Conclusion 36 Sanofi is a multinational pharmaceutical company Problem Retention of employee in same position Overcome by investment on employee Evaluation Increase loyalty , encourage people to improve and success and high performance and achievement
  • 37. 37